Quick Answer
MARAVAI LIFESCIENCES HOLDINGS, INC. reported Stockholders Equity of $212.38 million for the year ending 2025.
- MARAVAI LIFESCIENCES HOLDINGS, INC. showed a decrease of -34.7% in Stockholders Equity from 2024 to 2025.
- This data is from MARAVAI LIFESCIENCES HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $112.61 million | Q2 2021: $193.92 million | Q3 2021: $302.64 million | Q1 2022: $382.56 million | Q2 2022: $456.59 million | Q3 2022: $503.76 million | Q1 2023: $521.52 million | Q2 2023: $520.57 million | Q3 2023: $519.29 million | Q1 2024: $410.66 million | Q1 2025: $300.61 million | Q2 2025: $265.86 million | Q3 2025: $245.44 million.
- Over the full 8 years of available data (2020 to 2025), MARAVAI LIFESCIENCES HOLDINGS, INC.'s Stockholders Equity has grown by 139.9%.
- Historical annual values: Fiscal year 2025: $212.38 million | Fiscal year 2024: $325.29 million | Fiscal year 2024: $344.90 million | Fiscal year 2024: $434.73 million | Fiscal year 2023: $416.75 million | Fiscal year 2022: $545.22 million | Fiscal year 2021: $315.50 million | Fiscal year 2020: $88.51 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: